Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...

Cindy Perettie; Executive Vice President of Kite; Gilead Sciences Inc. Geoffrey Meacham; Analyst; Citi. Terence Flynn; Analyst; Morgan Stanley. Timothy Anderson; Analyst; BofA Glo ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

The decision by U.S. District Judge John Bates, a George W. Bush appointee, came after a testy Monday afternoon hearing.

One of the most devastating events in Emmerdale 's timeline unfolded in December 1993 when a plane crashed into the village, causing widespread destruction and multiple fatalities. This shocking ...

IndyGo is hosting a series of events around Indianapolis to answer questions about the Blue Line, the city's next rapid bus ...

About $238 million worth of health supplies have been stuck in warehouses and transit following the President Donald Trump’s ...

EGRIFTA SV® is distributed in the United States only.

Chemonics, a company that runs the Global Health Supply Chain Program, the largest USAID project ever, had $240 million in ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

The nonprofit’s leadership initially told staff the closure would be a “gradual" process ending in April, but that timeline has been moved up. Some clients don't know where they will go for medical ...